Another major advance in cell reprogramming and in obtaining iPS cells was achieved by researchers at Osaka and Kyoto universities, led by Masoto Nakagawa and Shinya Yamanaka, who succeeded in developing a method by which the cells generated have a lower risk of infection when transplanted. To achieve this, they used laminin-511, a synthetic protein (Scientific Reports online 8-I-2014).
Reduced the risk of infection by iPS cells when transplanted
About the Author: Prueba
This site uses Akismet to reduce spam. Learn how your comment data is processed.